Sequenom Inc (SQNM.OQ)
|Market Cap (Mil.):||$286.98|
|Shares Outstanding (Mil.):||115.72|
- Sequenom Inc, a maker of diagnostic tests, said it is exploring a full range of strategic options for its genetic analysis business.
- Shares of Sequenom Inc fell as much as 36 percent, a day after the life sciences company reported a jump in its second-quarter loss and prompted analysts to slash their ratings and price targets on the stock.
- Life sciences company Sequenom Inc reported a bigger-than-expected quarterly loss as changes made by the Centers for Medicare & Medicaid Services to billing codes delayed reimbursements on its tests.
Earnings vs. Estimates
Analyst Research Reports
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: TheStreet.com Ratings
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.